youtube_live
Q2 2027 earnings • 7:00 AM tomorrow
See detailschevron_right
RUBICON:NSE
Rubicon Research Ltd
₹1,710.70
arrow_downward
-0.42%(-7.30) 1D
Nov 4, 3:30:03 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RUBICON...
Open
₹1,718.00
High
₹1,728.50
Low
₹1,705.00
Mkt. cap
283.18B
Avg. vol.
224.79K
Volume
81.94K
Dividend
0.09%
Quarterly dividend
₹0.38
Ex-dividend date
Aug 7, 2026
P/E ratio
98.01
52-wk high
₹1,899.00
52-wk low
₹609.25
EPS
₹17.45
No. of employees
1K
Open
₹1,718.00
High
₹1,728.50
Low
₹1,705.00
Mkt. cap
283.18B
Avg. vol.
224.79K
Volume
81.94K
Dividend
0.09%
Quarterly dividend
₹0.38
Ex-dividend date
Aug 7, 2026
P/E ratio
98.01
52-wk high
₹1,899.00
52-wk low
₹609.25
EPS
₹17.45
No. of employees
1K
News stories
From web sources and news partners
Virginia Business
·
1 hour ago
Accendra Health could be delisted by NYSE
Springfield News-Sun
·
5 minutes ago
Stocks surge, and the Dow soars 1,500 points as oil prices tumble following the US midterm elections
Yahoo Finance
·
32 minutes ago
Expedia (NASDAQ:EXPE) posts better-than-expected sales in Q3 2026 but stock drops
Profile
Rubicon Research is an Indian pharmaceutical company located in Mumbai.
The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, manufacturing plants located in Ambernath, Satara and Pithampur, India, and a regulatory office in East Windsor, US. Wikipedia
About Rubicon Research Ltd
CEO-
Employees1.29K
Founded1999
Headquarters-
SectorPharmaceutical industry
Industry-
Websiterubicon.co.in